Javier Pagonabarraga

Best Publications

• Overdependence on degraded gist memory in Alzheimer's disease.

  David A. Gallo;Kameron R. Shahid;Meredith A. Olson;Todd M. Solomon

  1499
  Citations

• Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis.

  D. Aarsland;K. Bronnick;C. Williams-Gray;D. Weintraub

  1004
  Citations

• Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment

  Javier Pagonabarraga;Jaime Kulisevsky;Antonio P Strafella;Antonio P Strafella;Paul Krack;Paul Krack

  591
  Citations

• Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.

  Javier Pagonabarraga;Jaime Kulisevsky;Gisela Llebaria;Carmen García-Sánchez

  418
  Citations

• Cognitive impairment and dementia in Parkinson's disease.

  Javier Pagonabarraga;Jaime Kulisevsky;Jaime Kulisevsky

  330
  Citations

• Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.

  Laia Rodriguez-Revenga;Irene Madrigal;Javier Pagonabarraga;Mar Xunclà

  303
  Citations

• Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

  Joan Martí-Fàbregas;Meritxell Gomis;Adrià Arboix;Aitziber Aleu

  288
  Citations

• Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia

  Jaime Kulisevsky;Javier Pagonabarraga;Berta Pascual‐Sedano;Carmen García‐Sánchez

  266
  Citations

• Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.

  Javier Pagonabarraga;Saul Martinez-Horta;Saul Martinez-Horta;Ramón Fernández de Bobadilla;Ramón Fernández de Bobadilla;Jesús Pérez

  246
  Citations

• Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.

  Jaime Kulisevsky;Javier Pagonabarraga

  228
  Citations

• Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.

  Núria Setó-Salvia;Jordi Clarimón;Javier Pagonabarraga;Berta Pascual-Sedano

  181
  Citations

• Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson's Disease

  Javier Pagonabarraga;Idoia Corcuera-Solano;Yolanda Vives-Gilabert;Gisela Llebaria

  176
  Citations

• Controlled study of decision-making and cognitive impairment in Parkinson's disease.

  Javier Pagonabarraga;Carmen García-Sánchez;Gisela Llebaria;Berta Pascual-Sedano Md

  173
  Citations

• Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease

  Saul Martinez-Horta;Jesus Perez-Perez;Erik van Duijn;Ramon Fernandez-Bobadilla

  165
  Citations

• Benefits of a prehospital stroke code system. Feasibility and efficacy in the first year of clinical practice in Barcelona, Spain.

  Belvís R;Cocho D;Martí-Fàbregas J;Pagonabarraga J

  132
  Citations

• Homocysteine and cognitive impairment in Parkinson's disease: a biochemical, neuroimaging, and genetic study.

  Maria C. Rodriguez-Oroz;Pablo Martínez Lage;Jose Sanchez-Mut;Isabel Lamet

  116
  Citations

• Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

  Javier Pagonabarraga;Carles Soriano-Mas;Gisela Llebaria;Marina López-Solà

  116
  Citations

• Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.

  Jaime Kulisevsky;Javier Pagonabarraga;Mercè Martinez-Corral

  113
  Citations

• The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders.

  Daniel Alcolea;Jordi Clarimón;María Carmona-Iragui;Ignacio Illán-Gala

  111
  Citations

• Minor hallucinations in Parkinson disease: A subtle symptom with major clinical implications.

  Abhishek Lenka;Javier Pagonabarraga;Pramod Kumar Pal;Helena Bejr-Kasem

  101
  Citations